AXONIS Therapeutics

AXONIS Therapeutics is advancing breakthrough drug discovery to develop first-in-class therapies for currently incurable neurological disorders, aiming to bring real change to patients, their families, and global healthcare systems. The company has a team of world-leading innovators, serial entrepreneurs, successful drug developers, proactive scientists, and passionate patient advocates. Adult-onset central nervous system (CNS) diseases represent an urgent, unmet, global, and growing burden, especially as more people are living longer. Neuronal degeneration and excitation/inhibition imbalance are fundamental issues in many debilitating neurological disorders. AXONIS is developing a neuronal rejuvenation therapy that enables CNS neurons to harness their intrinsic capabilities.